A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen - PMC
Gene expression profiling classifies breast cancer into intrinsic subtypes based on the biology of the underlying disease pathways. We have used material from a prospective randomized trial of tamoxifen versus placebo in premenopausal women with ...
Clin Cancer Res . Author manuscript; available in PMC: 2013 Aug 14. Published in final edited form as: Clin Cancer Res. 2012 Jun 18;18(16):4465–4472. doi: 10.1158/1078-0432.CCR-12-0286 A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen Stephen K Chia Stephen K Chia 1 Department of Medical Oncology, British Columbia Cancer Agency (BCCA) Find articles by Stephen K Chia 1 , Vivien H Bramwell Vivien H Bramwell 3 Department of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta Find articles by Vivien H Bramwell 3 , Dongsheng Tu Dongsheng
related reading
- Mutational interactions define novel cancer subgroupsnature.com
- Research advances in treatment strategies for breast cancer liver metastases: A comprehensive review - PMCpmc.ncbi.nlm.nih.gov
- Epigenetic regulation during cancer transitions across 11 tumour typesnature.com
- Using Interpretability to Identify a Novel Class of Alzheimer's Biomarkersgoodfire.ai
- Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for non-small cell lung cancer undergoing radical surgerynature.com
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanomanature.com
- CNIH4: a novel biomarker connected with poor prognosis and cell proliferation in patients with lower-grade gliomapmc.ncbi.nlm.nih.gov
- In Brief: Classifications in Brief: Enneking Classification: Benign and Malignant Tumors of the Musculoskeletal System - PMCncbi.nlm.nih.gov
- Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance - PMCncbi.nlm.nih.gov
- Cancer cells educate natural killer cells to a metastasis-promoting cell state - PMCpmc.ncbi.nlm.nih.gov
- Loss and revival of androgen receptor signaling in advanced prostate cancernature.com
- The current state of the art and future trends in RAS-targeted cancer therapiesnature.com